Tatyana Sentsova

Tatyana Sentsova

Auto-generated profile, based on publicly available information

Tatyana Sentsova

Institute of Nutrition, Ustinsky Proezd, 2/14, Moscow 109240, Russia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
Vasily A. IsakovVasily A. Isakov
Vasily A. Isakov
ABAlexandra A. Bogdanova
Alexandra A. Bogdanova
VBVladimir Bessonov
Vladimir Bessonov
TSTatiana B. Sentsova
Tatiana B. Sentsova
VTViktor A. Tutelyan
Viktor A. Tutelyan
RVRod Velliquette
Rod Velliquette
The primary objective of this clinical study was to evaluate the effect of a dietary multivitamin, multimineral and phytonutrient (VMP) supplement on blood nutrient status and biomarkers of heart health risk in a Russian population. One hundred twenty healthy adults (40–70 years) were recruited for a 56-day (eight-week) randomized, double blind, placebo controlled study with parallel design. Subjects were divided into two groups and received either a VMP or a placebo (PLA) supplement. Blood nutrient levels of β-carotene, α-tocopherol, vitamin C, B6, B12, red blood cell (RBC) folate, Zinc and Selenium were measured at baseline and on Days 28 and 56, and quercetin was measured at baseline and on Day 56. Blood biomarkers of heart health, i.e. homocysteine (Hcy), high-sensitivity C-reactive protein (hs-CRP), oxidized LDL (ox-LDL), gamma-glutamyl transferase (GGT), uric acid and blood lipid profile, were measured at baseline and Day 56. Dietary VMP supplementation for 56 days significantly increased circulating levels of quercetin, vitamin C, RBC folate and partially prevented the decline in vitamin B6 and B12 status. Both serum Hcy and GGT were significantly reduced (−3.97 ± 10.09 µmol/L; −1.68 ± 14.53 U/L, respectively) after VMP supplementation compared to baseline. Dietary VMP supplementation improved the nutrient status and reduced biomarkers of heart health risk in a Russian population.

26 June 2016 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
TSTatyana Sentsova
Tatyana Sentsova
OCOlga Chernyak
Olga Chernyak
IVIlya Vorozhko
Ilya Vorozhko
KGKamila Gapparova
Kamila Gapparova
OGOlga Grigoryan
Olga Grigoryan
ACAlexandra Churycheva
Alexandra Churycheva
Objectives: The aim of the study was to investigate the genetic predictors of standard low-calorie diet at different polymorphic variations ApoE and LPL genes in obese patients.Materials and methods: Our study involved 88 obese patients aged 19 to 67 years (27 men and 61 women, mean age 38.40 ± 2.82 years and the average BMI 41.71 ± 1.23). Study of lipid metabolism includes the determination of total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein determined by spectrophotometry and immuno turbidimetry. Analysis of polymorphisms of LPL gene Ser447Ter (c.1595CG), Cys112Arg (c.388TC) and Arg158Cys (c.526CT) of ApoE gene was performed by polymerase chain reaction.Results: The results show significant differences in the efficacy of diet, depending on the genotype. We found that obese patients have significantly higher carrier genotypes c.388 T/T + c.526 C/C (by 20% reduced total cholesterol, by 19% – triglycerides, by20 % – low density lipoprotein, by 16% – high density lipoprotein, and by 9% – glucose), c.388 T/T + c.526 C/T ApoE gene (by 24% reduced total cholesterol, by 20% – triglycerides, and by 2% increased level of high-density lipoprotein) and C/C LPL gene (by 18% reduced total cholesterol concentration, by 17% – triglycerides, by 16% – high density lipoprotein, by 18% – low density lipoprotein, and by 9% – glucose).Conclusions: Thus, ApoE and LPL genes alleles can be used as biomarkers of prognosis of efficiency of a standard low-calorie diet therapy in obese patients.

30 March 2017 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
N(Network for Online Registration of Anaphylaxis (NORA)
Network for Online Registration of Anaphylaxis (NORA)
GPGuillaume Pouessel
Guillaume Pouessel
TSThe Anaphylaxis Working Group of the French Allergology SocietyThe Anaphylaxis Working Group of the French Allergology Society
The Anaphylaxis Working Group of the French Allergology SocietyThe Anaphylaxis Working Group of the French Allergology Society
CCClaire Claverie
Claire Claverie
JLJulien Labreuche
Julien Labreuche
CJCarla Jones
Carla Jones

25 October 2015 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
ILIrina Lapik
Irina Lapik
KGKamila Minkailovna Gapparova
Kamila Minkailovna Gapparova
OGOlga Nikolaevna Grigoryan
Olga Nikolaevna Grigoryan
KSKhaider Khamzyarovich Sharafetdinov
Khaider Khamzyarovich Sharafetdinov
ESElena Yur'Evna Sorokina
Elena Yur'Evna Sorokina
ASAndrew Arnol'Dovich Sokolnikov
Andrew Arnol'Dovich Sokolnikov
Introduction. Type 2 diabetes mellitus (type 2) is a major health problem worldwide. The progression of type 2 diabetes is contributed by usual for this patient group number of micronutrient deficiencies. Aim. To study the micronutrient status in patients with type 2 diabetes and obesity on the basis of molecular genetic studies. Materials and methods. The study involved 80 women with type 2 diabetes and obesity of I-II degree. All patients were tested for vitamin C, B6, B12, folate, a 25-hydroxyvitamin D, as well as potassium, magnesium, calcium, zinc and phosphorus in serum. DNA was isolated from blood by standard method using multicomponent lysis solution. Genotyping was performed using allele-specific amplification detection results in real time. Results. Comparative analysis of the manifestations of the polymorphic marker rs659366 UCP2 gene in patients with type 2 diabetes and obesity showed that the genotype of T/T and C/T is characterized by a low content of vitamin C in the serum than genotype of C/C. Polymorphism rs1801133 of MTHFR gene in patients with type 2 diabetes and obesity revealed that genotype C/T and T/T showed a lower content of vitamins B6, B12, folate in serum as compared with those indices in genotype C/C. Conclusion. The recommendation of vitamin-mineral complexes to patients with type 2 diabetes and obesity should be quided by molecular genetic studies, which might individually appoint the necessary micronutrients to improve the metabolic performance and reduce the risk of vascular complications in these patients.